EICHOR
● Active Not Recruiting
Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06)
Condition: PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC · Sponsor: Genmab
About this study
This is a multicenter, randomized, open-label, international, Phase 3 trial to evaluate the efficacy and safety of acasunlimab in combination with pembrolizumab versus docetaxel (standard of care) in participants with locally advanced (unresectable stage IIIB/C) or programmed death ligand 1 (PD-L1)-positive metastatic non-small cell lung cancer (NSCLC) who have been treated with programmed cell death protein 1 (PD-1)/PD-L1 inhibitor and platinum-containing chemotherapy, administered either in combination or sequentially in the locally advanced (unresectable stage IIIB/C) or metastatic setting.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (247)
| Arizona Blood and Cancer Specialists | Tucson, Arizona, United States | — |
| Usc Norris Comprehensive Cancer Center | Los Angeles, California, United States | — |
| Kaiser Permanente Vallejo Medical Center | Vallejo, California, United States | — |
| Ocala Oncology Center P.L. | Ocala, Florida, United States | — |
| Orlando Regional Medical Center | Orlando, Florida, United States | — |
| University Cancer & Blood Center, LLC | Athens, Georgia, United States | — |
| Piedmont Cancer Institute Atlanta | Atlanta, Georgia, United States | — |
| Piedmont Cancer Institute - Sandy Springs (Atlanta) Office | Atlanta, Georgia, United States | — |
| Piedmont Cancer Institute - Fayetteville Office | Fayetteville, Georgia, United States | — |
| Piedmont Cancer Institute - Newnan Office | Newnan, Georgia, United States | — |
| Piedmont Cancer Institute - Stockbridge Office | Stockbridge, Georgia, United States | — |
| Kaiser Foundation Hospitals | Honolulu, Hawaii, United States | — |
+ 235 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06635824